This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
3 LM Askie , L Duley , DJ Henderson-Smart , LA Stewart . Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data. Lancet 2007; 369: 1791–798.
6 SA Lowe , MA Brown , GA Dekker , S Gatt , CK McLintock , LP McMahon et al.Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol 2009; 49: 242–46.
8 KH Nicolaides . Turning the pyramid of prenatal care. Fetal Diagn Ther 2011; 29: 183–96.
9 E Bujold , S Roberge , Y Lacasse , M Bureau , F Audibert , S Marcoux et al.Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: A meta-analysis. Obstet Gynecol 2010; 116: 402–14.
10 E Bujold , S Roberge , S Tapp , Y Giguere . Opinion & hypothesis could early aspirin prophylaxis prevent against preterm birth? J Matern Fetal Neonatal Med 2011; 24: 966–67.
14 A Bakhti , D Vaiman . Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation. Hypertension Research 2011; 34: 1116–120.
17 A Benigni , G Gregorini , T Frusca , C Chiabrando , S Ballerini , A Valcamonico et al.Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989; 321: 357–62.
19 RC Hermida , DE Ayala , M Iglesias , A Mojon , I Silva , R Ucieda et al.Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women. Hypertension 1997; 30: 589–95.
21 M Tulppala , M Marttunen , V Soderstrom-Anttila , T Foudila , K Ailus , T Palosuo et al.Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: Effect on prostacyclin and thromboxane a2 production. Hum Reprod 1997; 12: 1567–572.
22 M Vainio , E Kujansuu , M Iso-Mustajarvi , J Maenpaa . Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG 2002; 109: 161–67.
23 S Roberge , P Villa , K Nicolaides , Y Giguere , M Vainio , A Bakthi et al.Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: A systematic review and meta-analysis. Fetal Diagn Ther 2012; 31: 141–46.
25Clasp: A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Clasp (collaborative low-dose aspirin study in pregnancy) collaborative group. Lancet 1994; 343: 619–29.
26 JS Moldenhauer , J Stanek , C Warshak , J Khoury , B Sibai . The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol 2003; 189: 1173–177.
27 NJ Sebire , RD Goldin , L Regan . Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity. J Obstet Gynaecol. 2005; 25: 117–18.
28 LJ Vatten , R Skjaerven . Is pre-eclampsia more than one disease? BJOG 2004; 111: 298–302.
29 X Xiong , NN Demianczuk , LD Saunders , FL Wang , WD Fraser . Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am J Epidemiol 2002; 155: 203–209.
30 RA Odegard , LJ Vatten , ST Nilsen , KA Salvesen , R Austgulen . Preeclampsia and fetal growth. Obstet Gynecol 2000; 96: 950–55.
31 R Xiao , TK Sorensen , MA Williams , DA Luthy . Influence of pre-eclampsia on fetal growth. J Matern Fetal Neonatal Med 2003; 13: 157–62.
32 CK Yu , O Khouri , N Onwudiwe , Y Spiliopoulos , KH Nicolaides . Prediction of pre-eclampsia by uterine artery doppler imaging: Relationship to gestational age at delivery and small-for-gestational age. Ultrasound Obstet Gynecol 2008; 31: 310–13.
33 E Groeneveld , KA Broeze , MJ Lambers , M Haapsamo , K Dirckx , BC Schoot et al.Is aspirin effective in women undergoing in vitro fertilization (IVF)? Results from an individual patient data meta-analysis (IPD MA). Hum Reprod Update 2011; 17: 501–509.
34 MJ Lambers , E Groeneveld , DA Hoozemans , R Schats , R Homburg , CB Lambalk et al.Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy. Hum Reprod 2009; 24: 2447–450.
35 M Haapsamo , H Martikainen , H Tinkanen , S Heinonen , S Nuojua-Huttunen , J Rasanen . Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: A randomized, placebo-controlled, double-blind study. Hum Reprod 2010; 25: 2972–977.
36 SP Kaandorp , M Goddijn , JA van der Post , BA Hutten , HR Verhoeve , K Hamulyak et al.Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010; 362: 1586–596.
37 CS Siristatidis , SR Dodd , AJ Drakeley . Aspirin is not recommended for women undergoing IVF. Hum Reprod Update 2012; 18: 233.
39 EA Steegers , P von Dadelszen , JJ Duvekot , R Pijnenborg . Pre-eclampsia. Lancet 2010; 376: 631–44.
41 R Pijnenborg , G Dixon , WB Robertson , I Brosens . Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1980; 1: 3–19
42 M Haapsamo , H Martikainen , J Rasanen . Low-dose aspirin reduces uteroplacental vascular impedance in early and mid gestation in IVF and ICSI patients: A randomized, placebo-controlled double-blind study. Ultrasound Obstet Gynecol 2008; 32: 687–93.
43 YM Kim , E Bujold , T Chaiworapongsa , R Gomez , BH Yoon , HT Thaler et al.Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2003; 189: 1063–1069.
44 YM Kim , T Chaiworapongsa , R Gomez , E Bujold , BH Yoon , S Rotmensch et al.Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002; 187: 1137–142.
47 MM Werler , AA Mitchell , S Shapiro . The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects. N Engl J Med 1989; 321: 1639–1642.
48 B Norgard , E Puho , AE Czeizel , MV Skriver , HT Sorensen . Aspirin use during early pregnancy and the risk of congenital abnormalities: A population-based case-control study. Am J Obstet Gynecol 2005; 192: 922–23.
49 MA Klebanoff , HW Berendes . Aspirin exposure during the first 20 weeks of gestation and IQ at four years of age. Teratology 1988; 37: 249–255.
50 SA Keim , MA Klebanoff . Aspirin use and miscarriage risk. Epidemiology 2006; 17: 435–39.
52 G Levy , JA Procknal , LK Garrettson . Distribution of salicylate between neonatal and maternal serum at diffusion equilibrium. Clin Pharmacol Ther 1975; 18: 210–14.
55 B Schiessl , KT Schneider , A Zimmermann , F Kainer , K Friese , R Oberhoffer . Prenatal constriction of the fetal ductus arteriosus–related to maternal pain medication? Z Geburtshilfe Neonatol 2005; 209: 65–68.
56 J Wyatt-Ashmead . Antenatal closure of the ductus arteriosus and hydrops fetalis. Pediatr Dev Pathol 2011; 14: 469–74.
57 TG Di Sessa , ML Moretti , A Khoury , DA Pulliam , KL Arheart , BM Sibai . Cardiac function in fetuses and newborns exposed to low-dose aspirin during pregnancy. Am J Obstet Gynecol 1994; 171: 892–900.
58 A Leonhardt , S Bernert , B Watzer , G Schmitz-Ziegler , HW Seyberth . Low-dose aspirin in pregnancy: Maternal and neonatal aspirin concentrations and neonatal prostanoid formation. Pediatrics 2003; 111: e77–81.
59 WA Bleyer , RT Breckenridge . Studies on the detection of adverse drug reactions in the newborn. II. The effects of prenatal aspirin on newborn hemostasis. JAMA. 1970; 213: 2049–2053.
60 DG Corby , I Schulman . The effects of antenatal drug administration on aggregation of platelets of newborn infants. J Pediatr 1971; 79: 307–13.
62 YE Rotchell , JK Cruickshank , MP Gay , J Griffiths , A Stewart , B Farrell et al.Barbados low dose aspirin study in pregnancy (blasp): A randomised trial for the prevention of pre-eclampsia and its complications. Br J Obstet Gynaecol 1998; 105: 286–92.
63 BM Sibai , SN Caritis , E Thom , M Klebanoff , D McNellis , L Rocco et al.Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The national institute of child health and human development network of maternal-fetal medicine units. N Engl J Med. 1993; 329: 1213–218.
64 S Caritis , B Sibai , J Hauth , MD Lindheimer , M Klebanoff , E Thom et al.Low-dose aspirin to prevent preeclampsia in women at high risk. National institute of child health and human development network of maternal-fetal medicine units. N Engl J Med 1998; 338: 701–705.
65 D Subtil , P Goeusse , F Puech , P Lequien , S Biausque , G Breart et al.Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: The essai regional aspirine mere-enfant study (part 1). BJOG 2003; 110: 475–84.
66 JC Hauth , RL Goldenberg , CR Parker Jr., GR Cutter , SP Cliver . Low-dose aspirin: Lack of association with an increase in abruptio placentae or perinatal mortality. Obstet Gynecol 1995; 85: 1055–1058
67 BM Sibai , SN Caritis , E Thom , K Shaw , D McNellis . Low-dose aspirin in nulliparous women: Safety of continuous epidural block and correlation between bleeding time and maternal-neonatal bleeding complications. National institute of child health and human developmental maternal-fetal medicine network. Am J Obstet Gynecol 1995; 172: 1553–557.
69 E Rey , GE Rivard . Is testing for aspirin response worthwhile in high-risk pregnancy? Eur J Obstet Gynecol Reprod Biol 2011; 157: 38–42.
70 M Vainio , J Maenpaa , A Riutta , P Ylitalo , SL Ala-Fossi , R Tuimala . In the dose range of 0.5–2.0 mg/kg, acetylsalicylic acid does not affect prostacyclin production in hypertensive pregnancies. Acta Obstet Gynecol Scand 1999; 78: 82–88
71 A Dumont , A Flahault , M Beaufils , E Verdy , S Uzan . Effect of aspirin in pregnant women is dependent on increase in bleeding time. Am J Obstet Gynecol 1999; 180: 135–40.
74 K Spencer , CK Yu , NJ Cowans , C Otigbah , KH Nicolaides . Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free BETA-HCG and with second-trimester uterine artery doppler. Prenat Diagn 2005; 25: 949–53.
75 LC Poon , NA Kametas , C Valencia , T Chelemen , KH Nicolaides . Hypertensive disorders in pregnancy: Screening by systolic diastolic and mean arterial` pressure at 11–13 weeks. Hypertens Pregnancy 2011; 30: 93–107.
76 R Akolekar , A Etchegaray , Y Zhou , N Maiz , KH Nicolaides . Maternal serum activin a at 11–13 weeks of gestation in hypertensive disorders of pregnancy. Fetal Diagn Ther 2009; 25: 320–27.
77 R Akolekar , R Minekawa , A Veduta , XC Romero , KH Nicolaides . Maternal plasma inhibin a at 11–13 weeks of gestation in hypertensive disorders of pregnancy. Prenat Diagn. 2009; 29: 753–60.
78 R Akolekar , A Syngelaki , J Beta , R Kocylowski , KH Nicolaides . Maternal serum placental protein 13 at 11–13 weeks of gestation in preeclampsia. Prenat Diagn 2009; 29: 1103–108.
79 G Karagiannis , R Akolekar , R Sarquis , D Wright , KH Nicolaides . Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11–13 weeks. Fetal Diagn Ther 2011; 29: 148–54.
80 LC Poon , NA Kametas , T Chelemen , A Leal , KH Nicolaides . Maternal risk factors for hypertensive disorders in pregnancy: A multivariate approach. J Hum Hypertens 2010; 24: 104–10.
81 LC Poon , NA Kametas , N Maiz , R Akolekar , KH Nicolaides . First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009; 53: 812–18.
82 LC Poon , NA Kametas , I Pandeva , C Valencia , KH Nicolaides . Mean arterial pressure at 11(+0) to 13(+6) weeks in the prediction of preeclampsia. Hypertension 2008; 51: 1027–1033
83 A Syngelaki , FE Bredaki , E Vaikousi , N Maiz , KH Nicolaides . Body mass index at 11–13 weeks’ gestation and pregnancy complications. Fetal Diagn Ther 2011; 30: 250–65.
84 GC Smith , CK Yu , AT Papageorghiou , AM Cacho , KH Nicolaides . Maternal uterine artery doppler flow velocimetry and the risk of stillbirth. Obstet Gynecol. 2007; 109: 144–51.
86 Y Giguere , M Charland , E Bujold , N Bernard , S Grenier , F Rousseau et al.Combining biochemical and ultrasonographic markers in predicting preeclampsia: A systematic review. Clin Chem 2010; 56: 361–75.
87 E Bujold , AM Morency , S Roberge , Y Lacasse , JC Forest , Y Giguere . Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery doppler: A systematic review and meta-analysis. J Obstet Gynaecol Can 2009; 31: 818–26.